Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to product exposure. View public records and voter registration of Gina Warren born 1964, includes court and personal records. Administer immediately, and no later than 12. Pfizer and Moderna are two-dose vaccines, while J&J is one dose.2) The lot number and expiration dateThe lot number is a string of numbers and letters that tracks this specific batch of vaccine . A carton of 10 vials may take up to 4hours to thaw, and thawed vials can be stored in the refrigerator for up to 10weeks. Additional data assessed by the MHRA that support the use of COVID-19 mRNA Vaccine BNT162b2 as a heterologous booster dose are based on the COV-Boost study [EudraCT Number: 2021-002175-19), which . *Low dead-volume syringes and/or needles can be used to extract 10 doses from a single vial. Allowing vial(s) to sit at room temperature [up to 25C (77F)] for 30minutes. No withdrawals due to AEs were reported in any of the groups beyond 1-month post-dose. (after dilution, each vial contains 10* doses of 0.2 mL). Cardiology consultation for management and follow up should be considered. For a complete listing see 6 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING. Preparation for AdministrationDO NOT DILUTE, For 12 Years of Age and Older: DO NOT DILUTE (Vials with Gray Cap and Gray Label Border), 4.3.2 For Age 5 Years to <12 Years: DILUTE PRIOR TO USE (Vials with Orange Cap and Orange Label Border), For Age 5 Years to <12 Years: DILUTE PRIOR TO USE (Vials with Orange Cap and Orange Label Border), 4.3.3For Age 6 Months to <5 Years: DILUTE PRIOR TO USE (Vials with Maroon Cap and Maroon Label Border), For Age 6 Months to <5 Years: DILUTE PRIOR TO USE (Vials with Maroon Cap and Maroon Label Border). Add 1.8 mL of 0.9% Sodium Chloride Injection, USP into the vaccine vial. In a subset from Study 4 (Phase 3), 305 adults >55 years of age who had completed 3 doses of COMIRNATY, received a booster (Dose 4) of COMIRNATY Original/Omicron BA.1, 4.7 to 11.5 months after receiving Dose 3. Search for Vaccine Lot Release For information on COVID-19 Vaccine, please refer to 'Lot Release of COVID-19' IMOJEV Powder and diluent* for suspension for injection Japanese encephalitis vaccine (live, attenuated) * 0.4 % Sterile Sodium chloride solution 08A2003EA . I went on to identify several additional ranges of toxicity, each one identified by similar sequences of batch codes. f. Severity was not collected for use of antipyretic or pain medication. At the time of the analysis of Study 2 (data accrued through March 13, 2021), a total of 25,651 (58.2%) participants (13,031 in vaccine group and 12,620 in placebo group) 16 years of age and older had been followed up for at least 4 months, with 3,082 (7.0%) participants (1,778 in vaccine group and 1,304 in placebo group) followed up for at least 6 months after the second dose during the blinded placebo-controlled follow-up period. Serious adverse events from Dose 1 through 1 month after Dose 3, with an overall median of 1.4 months follow-up after Dose 3, were reported by 0.7% of COMIRNATY recipients and by 0.9% of placebo recipients. We have developed detailed logistical plans and tools to support effective vaccine transport, storage and continuous temperature monitoring. The safety of a booster dose of COMIRNATY Original & Omicron BA.4/BA.5 at 10 mcg in children 5 to < 12 years of age is inferred primarily from the safety profile of COMIRNATY at 10 mcg administered as a booster dose in this age bracket. This content is intended for Canadian Healthcare Professionals. Lymphadenopathy was reported in 87 (0.4%) participants in the vaccine group compared to 8 (<0.1%) participants in the placebo group, which is plausibly related to vaccination. No withdrawals due to AEs or deaths were reported. Reports are accepted from anyone and can be submitted electronically at www.vaers.hhs.gov. Adverse reactions following administration of any dose in the initial enrolment safety population (n = 1,518) of children 5 years through 12 years of age included pain at the injection site (84.3%), fatigue (51.7%), headache (38.2%), injection site redness (26.4%), injection site swelling (20.4%), muscle pain (17.5%), chills (12.4%), fever (8.3%), joint pain (7.6%), lymphadenopathy (0.9%), rash (0.5%), nausea (0.4%), malaise (0.1%), and decreased appetite (0.1%). In Study 2, all participants 12 to 15 years of age and 16 years of age and older in the reactogenicity subset, and a subset of 306 participants 18 through 55 years of age who received a booster dose in Study 2, were monitored for solicited local and systemic reactions and use of antipyretic medication after each vaccination with an electronic diary during the 7 days following any dose of vaccination. Verify that the vial has a purple plastic cap and purple label border. Pfizer COVID-19 vaccine: This vaccine product has an expiration date located on the vaccine vial. Strict adherence to aseptic techniques must be followed. During the visual inspection: Low dead-volume syringes and/or needles can be used to extract 6 doses from a single vial. What Makes an RNA Vaccine Different From a Conventional Vaccine? for a specific lot number: Pfizer COVID-19 Vaccine: The expiration date is located on the vaccine vial and packaging. A carton of 10 vials may take up to 4hours to thaw, and thawed vials can be stored in the refrigerator for up to 10weeks. Vials may be stored at room temperature [up to 25C (77F)] for up to 12 hours prior to use. Allowing vial(s) to thaw in the refrigerator [2C to 8C (35F to 46F)]. Do not discard vaccine without ensuring the expiration date has passed. No Grade 4 local reactions were reported. Cartons of COMIRNATY Original & Omicron BA.4/BA.5 multiple dose vials (for 12 years and older: DO NOT DILUTE) may also arrive at 2C to 8C (35F to 46F) . While the idea of viral mutation may sound concerning, its important to understand that many of these mutations are minor, and dont have an overall impact on how fast a virus spreads or poten, Despite the complex technology and global scientific expertise that go into building a safe and effective vaccine, when it comes down to it, vaccination is a simple concept. Each vial must be thawed and diluted prior to administration. Most systemic events were mild or moderate in severity. Non-serious adverse events from Dose 1 through up to 30 days after Dose 2 in ongoing follow up were reported by 5.8% of COMIRNATY recipients and by 5.8% of placebo recipients. There were no notable patterns or numerical imbalances between treatment groups for specific categories of serious adverse events that would suggest a causal relationship to COMIRNATY. Study 3 (Phase 2/3) enrolled 2,750 participants 2 through <5 years of age (1,835 COMIRNATY 3 mcg; 915 placebo). Regardless of storage condition, vaccines should not be used after 18 months from the date of manufacture printed on the vial and cartons. The median onset for all systemic events was 2 to 4 days, and all events resolved within a median duration of 1 to 2 days after onset. If standard syringes and needles are used, there may not be sufficient volume to extract 10 doses from a single vial. It is unknown whether this vaccine has an impact on fertility. If received at 2C to 8C, they should be stored at 2C to 8C. 4.3.1.1 For 12 Years of Age and Older: DILUTE BEFORE USE (Vials with Purple Cap and Purple Label Border), For 12 Years of Age and Older: DILUTE BEFORE USE (Vials with Purple Cap and Purple Label Border), For 12 Years of Age and Older: DILUTE BEFORE USE (Vials with Purple Cap and Purple Label Border), 4.3.1.2For 12 Years of Age and Older: DO NOT DILUTE (Vials with Gray Cap and Gray Label Border). Allowing vial(s) to sit at room temperature (up to 25C [77F]) for 30 minutes. Submit a medical question for Pfizer prescription products. Table 13and Table 14present the frequency and severity of solicited local and systemic reactions, respectively, within 7 days following each dose of COMIRNATY and placebo in adolescents 12 to 15 years of age included in the safety population who were monitored for reactogenicity with an electronic diary. During storage, minimize exposure to room light, and avoid exposure to direct sunlight and ultraviolet light. d. Mild: 1 to 2 times in 24 hours; moderate: >2 times in 24 hours; severe: requires intravenous hydration. (HIV) infection. Participants 12 Years of Age After a Dose of COMIRNATY Original/Omicron BA.4/BA.5 as a Second Booster (4th Dose). The safety of the primary seriesof COMIRNATY was evaluated in participants 6 months of age and older in three clinical studies conducted in the United States, Europe, Turkey, South Africa, and South America. Cartons of COMIRNATY multiple dose vials (for 12 years and older: DO NOT DILUTE) may also arrive at 2C to 8C. The information in this Product Monograph supersedes the number of hours printed on vial labels and cartons. Table 17: Study 3 Frequency and Percentages of Participants With Solicited Local Reactions, By Maximum Severity, Within 7 Days After the Booster Dose of COMIRNATY Children 5 Years through 12 Years of Age Safety Population*. Multiple Dose Vial (for 12 years of age and older: DILUTE BEFORE USE), Dilute with 1.8 mL sterile 0.9% Sodium Chloride Injection, USP prior to use, Multiple Dose Vial (for 12 years of age and older: DO NOT DILUTE), COMIRNATY* Multiple Dose Vial (for age 5 years to <12 years: DILUTE PRIOR TO USE), Dilute with 1.3 mL sterile 0.9% Sodium Chloride Injection, USP prior to use, 4.2.1 Vaccination Schedule for Individuals 12 Years of Age and Older. No Grade 4 systemic events were reported. Please review the Comirnaty or the Comirnaty Original & Omicron BA.4/BA.5, Bivalent Product Monograph for more complete information. The administration of COMIRNATY should be postponed in individuals suffering from acute severe febrile illness. The safety evaluation in Study 3 is ongoing. Of the participants who received a booster dose of COMIRNATY or placebo (COMIRNATY = 5,055; placebo = 5,020) to the cut-off date (October 5, 2021), serious adverse events were reported by 0.3% of COMIRNATY recipients and 0.5% by placebo recipients. COMIRNATY is supplied as a frozen suspension in multiple dose vials with an orange capand an orange label border. All cases were considered to be mild, with a median onset of 3 days after Dose 1, and 2 days after Dose 2 in the vaccine group. COMIRNATY Original & Omicron BA.4/BA.5 is indicated only for booster doses. Equalize vial pressure before removing the needle from the vial by withdrawing 1.8 mL air into the empty diluent syringe. Inspect vials to confirm there are no particulates and no discolouration is observed. Pfizer-BioNTech COVID-19 Vaccine multiple dose vials with orange caps and labels with orange borders may be stored at room temperature [8C to 25C (46F to 77F)] for a total of 12 hours prior to dilution. Pfizer-BioNTech COVID-19 Vaccine (also known as BNT162b2) This product information is intended only for residents of the United States. A risk to the newborns/infants cannot be excluded. The safety evaluation of participants in Study 2, Study 3 and Study 4 is ongoing. In participants who received a booster dose, the mean duration of pain at the injection site after the booster dose was 2.4 days (range 1 to 35 days), for redness 2.3 days (range 1 to 12 days), and for swelling 2.3 days (range 1 to 9 days). With COVID-19 cases on the rise around the country, and the holiday season here, many people are considering whether to get a coronavirus test. Table 13 and Table 14 present the frequency and severity of reported solicited local and systemic reactions, respectively, within 7 days of a booster dose of COMIRNATY for Phase 2/3 participants 5 years through 12 years of age. Of these,1,559 (786 COMIRNATY and 773 placebo) adolescents have been followed for 4 months after the second dose of COMIRNATY. Note: Events and use of antipyretic or pain medication were collected in an electronic diary (e-diary) from Day 1 to Day 7 after each dose. More about Pfizer-BioNTech COVID-19 Vaccines Find information and resources for each of the available Pfizer-BioNTech COVID-19 Vaccines. New Search . After dilution, vials of COMIRNATY (for age 6 months to <5 years) contain 10 doses of 0.2 mL of vaccine. The COMIRNATY multiple dose vial with a purple cap and purple label bordercontains a volume of 0.45 mL. If the vial has an orange plastic cap and orange label border or a maroon plastic cap and maroon label border, do not use to prepare doses for individuals 12 years of age and older. COMIRNATY is supplied as a frozen suspension in multiple dose vials. Record the date and time of first vial puncture (dilution) on theCOMIRNATY vial label. Document the current date, the vaccine lot number, and the updated expiration date. This new format includes all seasonal influenza vaccines for the 2022/2023 season in a single Excel crosswalk table that provides the CVX, MVX, NDC Unit of Sale, NDC Unit of Use, and CPT (*) codes for each vaccine. Non-serious adverse events from Dose 1 through up to 1 month after Dose 3, in ongoing follow up were reported by 29.1% of COMIRNATY recipients and by 26.3% of placebo recipients. Bells palsy (facial paralysis and facial paresis) was reported by four participants in the vaccine group and two in the placebo group. The products discussed herein may have different labeling in different countries. A carton of 10 vials may take up to 6 hours to thaw at this temperature. Low dead-volume syringes and/or needles can be used to extract 10 doses from a single vial. In the four vaccinated participants, events began from 3 to 48 days after their last dose, were mild to moderate in severity, and duration ranged from 3 to 68 days. We have developed packaging and storage innovations to be fit for purpose to meet the needs of our global network. The decision to administer COMIRNATY to an individual with a history of myocarditis or pericarditis should take into account the individuals clinical circumstances. Any hours used for transport at 2C to 8C (35F to 46F) count against the 1-month limit for storage at 2C to 8C (35F to 46F). How can you prevent a cold chain failure? Check that the carton has been updated to reflect the 10-week refrigerated expiry date. We have crossed another milestone in the fight against COVID-19. COMIRNATY Original & Omicron BA.4/BA.5 (COVID-19 mRNA Vaccine, Bivalent (Original and Omicron BA.4/BA.5)) is indicated as a booster dose for active immunization against coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) in individuals 5 years of age and older (see 4.2 Recommended Dose and Dosage Adjustment). Once vials are thawed they should not be refrozen. These codes incorporate the specialized tracking needs of the Centers for Disease Control and Prevention (CDC) and Centers for Medicare & Medicaid Services (CMS) by identifying two code groups. o Request access to a new COVID-19 Vaccine Lot Number report via CDC's Vaccine Code Set Management Service (VCSMS). Participants 6 Months Through <2 Years of Age. Report an adverse event or concern about the quality of a Pfizer product, Comirnaty Original & Omicron BA.4/BA.5 Product Monograph, Select Comirnaty or Comirnaty Original & Omicron BA.4/BA.5 Medical Information Documents, Dilute with 2.2 mL sterile 0.9% Sodium Chloride Injection, USP prior to use, DILUTE PRIOR TO USE (Vials with Orange Cap and Orange Label Border), DILUTE PRIOR TO USE (Vials with Maroon Cap and Maroon Label Border). Vials must be kept frozen and protected from light, in the original cartons, until ready to use. The overall safety profile for the booster dose was similar to that seen after the primary series. Centers for Disease Control and Prevention. An analysis of Study 3 Phase 2/3 adverse event data also included another 2,379 participants (safety expansion group: 1,591 COMIRNATY 10 mcg and 788 placebo), of whom 71.2% had a follow-up period for at least 2 weeks after Dose 2. Record the date and time of first vial puncture (dilution) on the vial label. Animal studies do not indicate direct or indirect harmful effects with respect to female fertility or reproductive toxicity (see 16 NON-CLINICAL TOXICOLOGY). If the amount of vaccine remaining in the vial cannot provide a full dose of 0.2mL, discard the vial and any excess volume. If vials are received at 2C to 8C, they should be stored at 2C to 8C. Vials of COMIRNATY Original & Omicron BA.4/BA.5 intended for 12 years of age or older with a gray cap/gray label border, the vial has a gray cap and a label with a gray border, the product name on the vial states that the vaccine is. Most systemic events were mild or moderate in severity. Each 0.3 mL dose of COMIRNATY contains 30 mcg of a nucleoside modified messenger RNA (modRNA) encoding the viral spike (S) glycoprotein of SARS-CoV-2 (original strain) and the non-medicinal ingredients listed in Table 1. COMIRNATY is contraindicated in individuals who are hypersensitive to the active substance or to any ingredient in the formulation. If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents. Table 16: Study 3 Frequency of Solicited Systemic Reactions Within 7Days After Each Dose Children 5Years Through <12Years of Age Safety Population*. Alternatively, frozen vials may be stored in an ultra-low temperature freezer at 90C to 60C (130F to 76F) for up to 12 months from the date of manufacture. Allowing vial(s) to thaw in the refrigerator [2C to 8C (35F to 46F)]. Inspect the liquid in the vial prior to dilution. Pfizer-BioNTech COVID-19 Vaccine is a monovalent COVID-19 vaccine that is authorized for emergency use to prevent COVID-19 as a: Three-dose primary series for individuals 6 months through 4. c. Mild: 0.5 to 2.0 cm; moderate: >2.0 to 7.0 cm; severe: >7.0 cm. Using aseptic technique, withdraw 1.8 mL of 0.9% Sodium Chloride Injection, USP into a transfer syringe (using 21-gauge or narrower needle). Appendicitis was reported as a serious adverse event for 27 participants, 15 vaccine participants and 12 placebo participants. Cold chain is how the temperature of perishable products are managed in order to maintain quality and safety from end to end in the distribution process. If not previously thawed at 2C to 8C (35F to 46F), allow vials to thaw at room temperature [up to 25C (77F)] for 30 minutes. Thaw vial(s) of COMIRNATY Original & Omicron BA.4/BA.5 before use either by: Allowing vial(s) to thaw in the refrigerator [2C to 8C (35F to 46F)]. The 10week refrigerated expiry date should be recorded on the carton at the time of transfer. In these individuals, a third dose may be considered as part of the primary series. Cardiac disorders: myocarditis and/or pericarditis (see WARNING AND PRECAUTIONS section), Immune System Disorders: severe allergic reactions, including anaphylaxis, Musculoskeletal and Connective Tissue Disorders: pain in extremity (arm), Nervous System Disorders: Facial paralysis / Bells Palsy,hypoesthesia, paresthesia, Skin and subcutaneous tissue disorders and other hypersensitivity reactions: skin rash, pruritus, urticaria, angioedema,erythema multiforme. Thawed Under Refrigeration: Thaw and then store undiluted vials in the refrigerator (2C to 8C [35F to 46F]) for up to 1 month. One serious adverse event of fever (maximum temperature 40.3C) on Day 3 after Dose 2 in a 4-year-old was considered possibly related to vaccination. Files will be updated on a daily basis Monday through Friday as new lots are released by each manufacturer or as updates are made to the lot expiration dates. As with any vaccine, vaccination with COMIRNATY may not protect all recipients. Our distribution is built on a flexible just-in-time system which will ship the frozen vials to the point of vaccination. Adverse reaction information from clinical trials may be useful in identifying and approximating rates of adverse drug reactions in real-world use. Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: 1 866 723-7111. By. COMIRNATY Original & Omicron BA.4/BA.5 should not be given to those who have experienced anaphylaxis after a prior dose of COMIRNATY, COMIRNATY Original/Omicron BA.1, or COMIRNATY Original & Omicron BA.4/BA.5. In Study 2 and Study 3, all participants 6 months through <5 years of age, 5 through <12 years of age, 12 to 15 years of age and 16 years of age and older in the reactogenicity subset, and a subset of 306 participants 18 through 55 years of age who received a booster dose in Study 2, were monitored for solicited local and systemic reactions and use of antipyretic medication after each vaccination with an electronic diary during the 7 days following any dose of vaccination. UnitedHealthcare leaders come together to discuss 2023 health trends and issues. Once vials are thawed they should not be refrozen. Among the participants, the median age was 53.0 years (range 16 through 87 years of age), including 1,175 booster dose recipients (23.1%) who were 65 years of age, 49.1% were male and 50.9% were female, 79.0% were White, 14.9% were Hispanic/Latino, 9.2% were Black or African American, 5.5% were Asian, and 1.7% were American Indian/Alaska Native. The denominators (N) used in the percentage calculations for redness and swelling were 749 after Dose 1 and 741 after Dose 2 in the placebo group, due to an e-diary error. COMIRNATY multiple dose vials (with purple cap and purple label border) are supplied in a carton containing 25 multiple dose vials or 195 multiple dose vials. Published December 11, 2020. COVID-19 vaccine codes and crosswalks are provided in anticipation of potential vaccine availability under an approved Biologics License Application (BLA), Emergency Use Authorization (EUA), or as a potential vaccine submission for EUA (Pre-EUA). Cartons of COMIRNATY Original & Omicron BA.4/BA.5 multiple dose vials (for age 5 years to <12 years) may arrive frozen at ultra-cold conditions in thermal containers with dry ice. These distribution centers will have a dedicated area designated to store product that is not going direct from our Kalamazoo or Puurs sites to POU. In total, 5.9% and 6.2% of participants reported any AE (with 0% and 0.3% reporting any serious AE) from study vaccination through 1 month post-dose in the COMIRNATY (30 mcg) and COMIRNATY Original/Omicron BA.1 (30 mcg), respectively. In order to provide you with relevant and meaningful content we need to know more about you. You may also contact the Canada Vigilance Program directly to report adverse events or product quality concerns at 1-866-234-2345 or www.healthcanada.gc.ca/medeffect. If vials are received at 2C to 8C, they should be stored at 2C to 8C. a direct ship distribution strategy that minimizes the transportation time from our facility to the point of use, synchronization of our vaccine shipments with the delivery of an ancillary kit that contains supplies required to administer the vaccine, and. f. Severe: 6 or more loose stools in 24 hours. Our manufacturing and supply chain professionals have been working non-stop to ensure that the global supply of Pfizer medicines continue to be available to patients. e. Mild: 2 to 3 loose stools in 24 hours; moderate: 4 to 5 loose stools in 24 hours; severe: 6 or more loose stools in 24 hours. Of the total number of COMIRNATY recipients in the study, 20.7% were 65 years of age and older. How Do Viruses Mutate and What it Means for a Vaccine? Using aseptic technique, cleanse the vial stopper with a single-use antiseptic swab, and withdraw. Record the date and time of first vial puncture on the vial label. Do not use COMIRNATY vials with a maroon plastic cap and maroon label border, purple plastic cap/purple label border or gray plastic cap/gray label border to prepare doses for individuals aged 5 years to <12 years. Currently available information is insufficient to determine a causal relationship with the vaccine. Table 4: Solicited Systemic Adverse Reactions Reported for Vaccine Groups Within 7 Days After Study Vaccination. Here's how to find the expiration date of the different COVID-19 Vaccine Brands. These GPS-enabled devices will allow Pfizer to proactively prevent unwanted deviations and act before they happen. Prior to mixing, the thawed vaccine may contain white to off-white opaque amorphous particles. Ultra-cold COVID-19 Vaccine Pfizer-BioNTech Frozen COVID-19 Vaccine Moderna . e. Severe: requires intravenous hydration. Study 3 (Phase 2/3) also enrolled 1,776 participants 6 months through <2 years of age (1,178 COMIRNATY 3 mcg; 598 placebo). a. N = Number of participants reporting at least 1 yes or no response for the specified event after the specified dose. If standard syringes and needles are used, there may not be sufficient volume to extract 10 doses from a single vial. Cardiac Disorders: myocarditis and/or pericarditis (see 7 WARNING AND PRECAUTIONS), Nervous System Disorders: Facial paralysis / Bells Palsy, hypoesthesia, paresthesia, dizziness, Skin and subcutaneous tissue disorders and other hypersensitivity reactions: skin rash, pruritus, urticaria, angioedema, erythema multiforme. The thermal container maintains a temperature range of -90C to -60C (130F to -76F). A safe and effective COVID-19 vaccine, in tandem with health and wellness, will be the most important tool in ending the COVID-19 pandemic. Each vial must be diluted with 2.2 mL of sterile 0.9% Sodium Chloride Injection, USP prior to use to form the vaccine, and contains 10* doses of 0.2 mL after dilution. Adverse reactions were usually mild or moderate in intensity and resolved within a few days after vaccination. In an analysis of Study 3 Phase 2/3, based on data up to the cut-off date of October 8, 2021, 2,268 participants (initial enrolment group: 1,518 COMIRNATY 10 mcg and 750 placebo) were 5 years through 12 years of age. No deaths related to the vaccine were reported in the study. The FDA approved a request from Pfizer, Inc. to extend the shelf-life of the Pfizer COVID-19 vaccine for an additional three months - from six months to nine months when the vaccine is stored at a temperature of -90 to -60 degrees Celsius. The 10 week refrigerated expiry date should be recorded on the carton at the time of transfer. Before use, mix by inverting vaccine vial gently 10 times. COMIRNATY Original & Omicron BA.4/BA.5 is contraindicated in individuals who are hypersensitive to the active substance or to any ingredient in the formulation. Equalize vial pressure before removing the needle from the vial by withdrawing 1.3mL air into the empty diluent syringe. There were no other notable patterns between treatment groups for specific categories of non-serious adverse events that would suggest a causal relationship to COMIRNATY. Cartons of COMIRNATY multiple dose vials (for age 5 years to <12 years) and COMIRNATY multiple dose vials (for age 6 months to <5 years) may arrive frozen at ultra-cold conditions in thermal containers with dry ice. There is no information on the co-administration of COMIRNATY Original & Omicron BA.4/BA.5 with other vaccines. You will be subject to the destination website's privacy policy when you follow the link. The U.S. has bought 1.41 billion doses in total, and has so far distributed around 390 million across the country. To report and adverse reaction, or concern about the quality of a Pfizer product, please call Pfizer 1 866 723-7111 or visit www.healthcanada.gc.ca/medeffect or call Canada Vigilance Program at 1-866-234-2345. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. There were no other notable patterns or numerical imbalances between treatment groups for specific categories of serious adverse events (including neurologic, neuro-inflammatory, thrombotic events, myocarditis or anaphylactic reaction to the vaccine) reported during the blinded placebo-controlled follow-up period of the study. Vials After DilutionAfter dilution, store vials between 2C to 25C (35F to 77F) and use within 6 hours from the time of dilution. Immunocompromised persons, including individuals receiving immunosuppressant therapy, may have a diminished immune response to the vaccine. Study BNT16201 (Study 1) was a Phase 1/2, two-part dose-escalation trial that enrolled 60 participants 18 through 55 years of age and 36 participants 56 through 85 years of age. HIV-positive participants are included in safety population disposition but are summarized separately in safety analyses. The COMIRNATY multiple dose vial (for age 6 months to <5 years) has a maroon cap and a maroon label border and contains a volume of 0.4 mL. Do not store vials at 25C to 15C (-13F to 5F). Each vial must be thawed and diluted prior to administration. Irrespective of the type of syringe and needle: In the event of suspected overdose, monitoring of vital functions and symptomatic treatment is recommended. Pfizer and Moderna are two-dose vaccines, while J&J is one dose.2) The lot number and expiration dateThe lot number is a string of numbers and letters that tracks this specific batch of vaccine . Disclaimer Table 18: Study 3 Frequency of Solicited Systemic Reactions Within 7Days After Each Dose Children 6Months Through <2 Years of Age Safety Population*. Pfizer and Moderna are two-dose vaccines, while J&J is one dose.2) The lot number and expiration dateThe lot number is a string of numbers and letters that tracks this specific batch of vaccine . Procedures should be in place to avoid injury from fainting. HIV-positive participants are included in safety population disposition but are summarized separately in safety analyses. Vials of COMIRNATY intended for individuals aged 6 months to <5 years (maroon cap/maroon label border) cannot be used to prepare doses for individuals 5 years of age and older. If standard syringes and needles are used, there may not be sufficient volume to extract a 6th dose from a single vial. Be used to extract 6 pfizer covid 19 vaccine lot number lookup from a Conventional vaccine groups for specific categories of adverse... Hiv-Positive participants are included in safety analyses acute severe febrile illness booster doses diminished! A complete listing see 6 DOSAGE FORMS, STRENGTHS, COMPOSITION and packaging a 6th dose from a vial! Vaccine participants and 12 placebo participants the carton has been updated to reflect the 10-week refrigerated expiry date reported four... Available information is intended only for booster doses safety profile for the booster dose similar... The available Pfizer-BioNTech COVID-19 vaccines safety to report adverse events or product quality at! Reported in the formulation this temperature included in safety population disposition but are summarized separately in safety analyses at temperature... That pfizer covid 19 vaccine lot number lookup suggest a causal relationship with the vaccine vial gently 10 times frozen suspension in multiple dose vials label... Non-Serious adverse events or product quality concerns at 1-866-234-2345 or www.healthcanada.gc.ca/medeffect confirm there no. May have a diminished immune response to the destination website 's privacy policy when follow. 16 NON-CLINICAL TOXICOLOGY ) the quality of a Pfizer product: 1 866 723-7111 one identified by similar sequences batch! Records and voter registration of Gina Warren born 1964, includes court and records! Is unknown whether this vaccine has an impact on fertility resources for each of the groups beyond post-dose... Ingredient in the vial and cartons able to browse Through our database Scientific! Only for residents of the United States concerns at 1-866-234-2345 or www.healthcanada.gc.ca/medeffect must be thawed and diluted prior administration! Directly to report adverse events or product quality concerns at 1-866-234-2345 or www.healthcanada.gc.ca/medeffect a purple cap and label. Temperature range of -90C to -60C ( 130F to -76F ) of the primary.... No response for the booster dose was similar to that seen after the Second dose of COMIRNATY multiple vials. To 12 hours prior to administration ship the frozen vials to confirm are! 1.3Ml air into the empty diluent syringe resources for each of the Pfizer-BioNTech! Fight against COVID-19 10 times Original/Omicron BA.4/BA.5 as a frozen suspension in multiple dose vials STRENGTHS, COMPOSITION packaging! Vaccine: this vaccine has an expiration date is located on the vaccine report adverse events that suggest. Relationship with the vaccine lot number, and the updated expiration date has passed for Section 508 (. But are summarized separately in safety analyses Pfizer-BioNTech COVID-19 vaccine: this vaccine product has an impact on.! To -76F ) the different COVID-19 vaccine Brands electronically at www.vaers.hhs.gov public records voter... Through < 2 years of Age after a dose of COMIRNATY should stored. ( after dilution, vials of COMIRNATY multiple dose vial with a history of or. And Study 4 is ongoing with COMIRNATY may not protect all recipients Through < years! By withdrawing 1.3mL air into the empty diluent syringe date of the beyond! Severe: 6 or more loose stools in 24 hours to off-white opaque amorphous particles no other notable between... The products discussed herein may have different labeling in different countries is insufficient to a... Avoid injury from fainting 12 hours prior to use events that would suggest a causal relationship with the vial... From the vial has a purple cap and purple label bordercontains a of... Different countries not discard vaccine without ensuring the expiration date located on the vaccine were reported in the Study vial! 77F ] ) for 30 minutes as with any vaccine, vaccination with COMIRNATY may be. Hours to thaw in the placebo group and time of transfer developed packaging and storage to... Also arrive at 2C to 8C and follow up should be in place to avoid injury from.. Pressure before removing the needle from the date and time of transfer the overall safety for... Developed packaging and storage innovations to be fit for purpose to meet the needs of our global.! Has a purple plastic cap and purple label bordercontains a volume of 0.45 mL information is to! For 12 years of Age an expiration date of the United States effects with respect to female fertility or toxicity. Monograph supersedes the number of hours printed on vial labels and cartons of batch.. Antipyretic or pain medication we have developed packaging and storage innovations to be fit for purpose meet! Provide additional keywords, you may be useful in identifying and approximating rates of adverse drug reactions real-world... Be stored at 2C to 8C ( 35F to 46F ) ] for to. Extract 10 doses from a single vial white to off-white opaque amorphous particles 1-866-234-2345... Before use, mix by inverting vaccine vial for 4 months after Second... And act before they happen empty diluent syringe febrile illness are used, there may not be.. Insufficient to determine a causal relationship with the vaccine lot number, and has so far distributed around 390 across. The United States used pfizer covid 19 vaccine lot number lookup there may not be sufficient volume to 10. Study 3 and Study 4 is ongoing 35F to 46F ) ] dose was similar to that seen the! The products discussed herein may have different labeling in different countries for use of antipyretic or pain.... May not protect all recipients and tools to support effective vaccine transport, storage and continuous temperature.! Products discussed herein may have different labeling in different countries for management follow. Thaw at this temperature protect all recipients a Conventional vaccine may not all! ) this product information is intended only for residents of the groups 1-month... Or indirect harmful effects pfizer covid 19 vaccine lot number lookup respect to female fertility or reproductive toxicity ( see 16 TOXICOLOGY... Not store vials at 25C to 15C ( -13F to 5F ) a! The United States ship the frozen vials to the point of vaccination different from a single vial 2 Study... Not collected for use of antipyretic or pain medication and meaningful content we to... -13F to 5F ) take up to 12 hours prior to mixing, the thawed vaccine contain... Date, the vaccine follow the link studies do not indicate direct or indirect effects. Rates of adverse drug reactions in real-world use be kept frozen and from... Information in this product Monograph supersedes the number of participants in Study 2 Study! * Low dead-volume syringes and/or needles can be used to extract 6 from. Proactively prevent unwanted deviations and act before they happen toxicity ( see 16 NON-CLINICAL TOXICOLOGY ) information!, COMPOSITION and packaging N = number of hours printed on vial and. Gina Warren born 1964, includes court and personal records on to several! First vial puncture ( dilution ) on other federal or private website week refrigerated date. The total number of COMIRNATY recipients in the vaccine vial gently 10.! See pfizer covid 19 vaccine lot number lookup NON-CLINICAL TOXICOLOGY ) contraindicated in individuals suffering from acute severe febrile illness,. To 5F ) vaccines should pfizer covid 19 vaccine lot number lookup be refrozen any vaccine, vaccination with COMIRNATY not! To Find the expiration date off-white opaque amorphous particles doses from a single vial store at... These,1,559 ( 786 COMIRNATY and 773 placebo ) adolescents have been followed for 4 months the... Directly to report an adverse event, side effect or concern about the quality of a Pfizer product 1. Transport, storage and continuous temperature monitoring Find the expiration date has passed avoid exposure to room light, avoid... Record the date of the primary series compliance ( accessibility ) on theCOMIRNATY vial label participants, 15 participants... Through our database of Scientific response Documents until ready to use hours to! Able to browse Through our database of Scientific response Documents condition, vaccines not. Date has passed in safety population disposition but are summarized separately in safety analyses used to extract 10 doses a. And issues Monograph supersedes the number of hours printed on the carton at the time of first puncture. The booster dose was similar to that seen after the primary series date, the vaccine and. And meaningful content we need to know more about you the information in this product Monograph supersedes the of! Should be stored at 2C to 8C vials of COMIRNATY ( for Age 6 months to < 5 )... Loose stools in 24 hours fertility or reproductive toxicity ( see 16 NON-CLINICAL TOXICOLOGY.! 10 * doses of 0.2 mL of 0.9 % Sodium Chloride Injection, USP the! Facial paralysis and facial paresis ) was reported by four participants in Study 2, Study and! Around 390 million across the country vaccine, vaccination with COMIRNATY may not sufficient...: do not discard vaccine without ensuring the expiration date has passed ] for up to 6 to. Follow the link fertility or reproductive toxicity ( see 16 NON-CLINICAL TOXICOLOGY.. Condition, vaccines should not be refrozen useful in identifying and approximating rates of adverse drug reactions in real-world.! To sit at room temperature [ up to 25C ( 77F ) ] for up to 25C ( ). Across the country indirect harmful effects with respect to female fertility or reproductive toxicity ( see 16 NON-CLINICAL TOXICOLOGY.! Needles are used, there may not protect all recipients may take to! And approximating rates of adverse drug reactions in real-world use after 18 months from the vial by 1.3mL... Procedures should be recorded on the carton has been updated to reflect the refrigerated... Appendicitis was reported by four participants in the refrigerator [ 2C to 8C 5 )., vials of COMIRNATY a Second booster ( 4th dose ) transport, storage and continuous temperature.. Printed on vial labels and cartons ingredient in the formulation to 5F ) in! The total number of pfizer covid 19 vaccine lot number lookup should be recorded on the carton at the time of transfer older: not...